Acadia Pharmaceuticals
ACAD
ACAD
226 hedge funds and large institutions have $2.75B invested in Acadia Pharmaceuticals in 2022 Q4 according to their latest regulatory filings, with 29 funds opening new positions, 73 increasing their positions, 81 reducing their positions, and 23 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding in top 10
Funds holding in top 10: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
2.02% more ownership
Funds ownership: 94.18% → 96.2% (+2%)
2% more funds holding
Funds holding: 222 → 226 (+4)
10% less repeat investments, than reductions
Existing positions increased: 73 | Existing positions reduced: 81
Holders
226
Holding in Top 10
6
Calls
$11.3M
Puts
$4M
Top Buyers
| 1 | +$275M | |
| 2 | +$17.8M | |
| 3 | +$16.1M | |
| 4 |
State Street
Boston,
Massachusetts
|
+$15.3M |
| 5 |
Man Group
London,
United Kingdom
|
+$14.8M |
Top Sellers
| 1 | -$35.6M | |
| 2 | -$20.7M | |
| 3 | -$12.3M | |
| 4 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$9.74M |
| 5 |
D.E. Shaw & Co
New York
|
-$7.85M |